Julius Mertins

Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors

U. Schüller, T. Albert, M. Meisterernst, 2022, Nature Communications.

Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors.

M. Kool, M. Meisterernst, P. Johann, 2017, Oncotarget.

Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1

M. Kool, U. Schüller, M. Meisterernst, 2014, International journal of cancer.